Cansera Inc.
Los Angeles, CA
- UEI
- KS4JGG27K1M6
- CAGE
- 872R4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1155 S Grand Ave, Los Angeles, CA 90015, USA
- Website
- cansera.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Topic 425 - automated motion extraction and analysis to quantify patient performance status | National Cancer Institute (NIH) | $2,304,939 |
SBA capabilities narrative
Cansera, Inc. applies advanced technology to enhance cancer screening, monitoring, and treatment with the ultimate goal of improving patient outcomes. Our work centers on next-generation rare cell detection technologies powered by modern software architecture, machine learning, and AI-driven analytics. Our flagship platform, CellLogic, identifies and characterizes rare events from fluorescent whole slide imaging (fWSI) of human whole blood and other liquid biopsy samples, enabling highly scalable and clinically relevant insights.
Quick answers
Is Cansera Inc. registered in SAM.gov?
Yes. Cansera Inc.'s SAM.gov registration is active through September 8, 2027.
What is Cansera Inc.'s most recent federal award?
Cansera Inc.'s most recent federal contract award is Topic 425 - automated motion extraction and analysis to quantify patient performance status (75N91021C00051), from National Cancer Institute (NIH), on September 15, 2021.
On GovTribe
See Cansera Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors